Regulus Therapeutics Inc (NASDAQ:RGLS)

0.6479
Delayed Data
As of 1:20pm ET
 -0.0055 / -0.84%
Today’s Change
0.63
Today|||52-Week Range
1.95
-37.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues7.7M20.8M1.2M72.0K
 
 
 
 
 
Depreciation And Amortization1.5M1.6M2.3M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses51.1M73.9M80.4M67.7M
 
 
 
 
 
Research And Development41.0M56.4M64.3M53.2M
 
 
 
 
 
Total Operating Expenses52.6M75.5M82.7M70.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-44.9M-54.8M-81.5M-70.1M
 
 
 
 
 
Extraordinary Charge-12.1M-1.8M0.000.00
 
 
 
Interest Expense On Debt39.0K52.0K1.2M2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-56.7M-55.8M-81.8M-72.1M
 
 
 
 
 
Income Taxes-1.0K-18.0K-4.0K-197.0K
 
 
 
 
 
Net Income-56.7M-55.7M-81.8M-71.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.1M51.4M52.8M75.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.1M51.4M52.8M75.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.29-$1.08-$1.55-$0.96
 
 
 
 
 
EPS Diluted-$1.29-$1.08-$1.55-$0.96